Search

Your search keyword '"Marques, Laura"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Marques, Laura" Remove constraint Author: "Marques, Laura"
311 results on '"Marques, Laura"'

Search Results

1. Leishmaniose

2. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics

5. TRATAMENTO MEDICAMENTOSO PARA OBESIDADE INFANTIL

6. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

7. First babies conceived with Automated Intracytoplasmic Sperm Injection

8. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

10. Minoxidil: main differences between topical and oral use

12. EDUCAÇÃO POPULAR EM SAÚDE E SUA RELEVÂNCIA NA ATENÇÃO BÁSICA: UMA REVISÃO NARRATIVA

13. Haemophilus influenzae Type b Vaccine Failure in Portugal: A Nationwide Multicenter Pediatric Survey

14. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

15. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

16. Psychological distress and the COVID-19 pandemic: the role of personality and coping strategies.

17. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

20. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

21. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia

22. CARDIOTOXICIDADE ASSOCIADA À TERAPÊUTICA ONCOLÓGICA

24. Variable immunodeficiency study: Evaluation of two European cohorts within a variety of clinical phenotypes

25. First Babies Conceived With Automated Intracytoplasmic Sperm Injection

27. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

28. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

32. Drug use, family support and related factors in university students. A cross-sectional study based on the uniHcos Project data

34. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

35. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration

36. PoDA Algorithm: Predictive Pathways in Colorectal Cancer

37. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis

39. The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium

41. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

42. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

44. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe

45. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation

46. O PERFIL CLÍNICO-EPIDEMIOLÓGICO DE GESTANTES ACOMETIDAS POR COVID-19 NA REGIÃO NORTE DO BRASIL

47. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe

49. VACCELERATE Site Network:Real-time definition of clinical study capacity in Europe

50. Global patterns of tree density are contingent upon local determinants in the world’s natural forests

Catalog

Books, media, physical & digital resources